AQUIPTA (atogepant) is a prescription medicine used to prevent migraine in patients who have at least 4 migraine days per month.3
References: 1. AQUIPTA® (atogepant) Data Sheet. 2. Schwedt TJ, et al. Cephalalgia. 2022;42(1):3-11. 3. AQUIPTA® (atogepant) Consumer Medicine Information.
NZ-AQP-240017. TAPS BG4309. ABB2630. Date prepared September 2024.